One Wnt/β-catenin target, jun, was widely expressed in non-HCC hepatocytes (52.6%), suggesting that the presence of jun mRNA is not indicative of aberrant Wnt/β-catenin signaling (Table S17). Here, JUN is linked to hepatocellular carcinoma.